M Meehan

881 citations
4 papers · 698 · 1 hit paper · h-index 3

Impact in

Papers in

    • Liver Disease and Transplantation 1
    • Hepatocellular Carcinoma Treatment and Prognosis 1
    • Organ Transplantation Techniques and Outcomes 1

M Meehan

4 papers receiving 688 citations

M Meehan's Hit Papers

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. 1997 · 691 citations
6910+9+19Years since publication200400600

Peers

M Meehan
Comparison fields: 5 of 38
  • Gastroenterology 101
  • Pulmonary and Respiratory Medicine 511
  • Oncology 228
  • Surgery 218
  • Hepatology 10
Replace V. Mutri with:
V. Mutri Italy
Hideaki Nishidoi Japan
Keisei Taku Japan
H J Meyer Germany
Kirstin Breithaupt Germany
Christian Gerges Germany
Han Mo Yoo South Korea
Dmitry Bichev Germany
Thomas G. Morales United States
H. Wilke Germany
M Meehan relative to V. Mutri Italy V. Mutri's profile →
Citations per field
00.5×
V. Mutri · 1×
Citations per year

Countries citing papers authored by M Meehan

Since Specialization
Citations

This map shows the geographic impact of M Meehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Meehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Meehan more than expected).

Fields of papers citing papers by M Meehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Meehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Meehan. The network helps show where M Meehan may publish in the future.

Co-authors

The 25 scholars most cited alongside M Meehan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M Meehan Line = papers co-authored together M Meehan links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Hit paper breakdown →
1997691
2 20013
3
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
19963
4 20031

About M Meehan

M Meehan is a scholar working on Hepatology, Surgery, General Health Professions, Oncology and Public Health, Environmental and Occupational Health, having authored 4 papers that have together received 698 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (1 paper), Renal Transplantation Outcomes and Treatments (1 paper), Patient-Provider Communication in Healthcare (1 paper), Cancer survivorship and care (1 paper), Palliative Care and End-of-Life Issues (1 paper), Liver Disease and Transplantation (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Gastroenterology (101 citations), Pulmonary and Respiratory Medicine (511 citations), Oncology (228 citations), Surgery (218 citations) and Hepatology (10 citations). M Meehan has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Andrew Wardley, Andrew Webb, Mary O’Brien, Andrew Hill, Peter Harper, J.H. Scarffe, Janine Mansi, David Cunningham, M Findlay and Timothy Iveson. Their work appears in journals such as Journal of Clinical Oncology, Hepatology, European Journal of Cancer Care and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact